Stephens & Co. Reiterates Equal-Weight on Molina Healthcare, Maintains $350 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Equal-Weight rating on Molina Healthcare (NYSE:MOH) and maintained a $350 price target.
October 03, 2023 | 4:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Molina Healthcare's stock rating has been reiterated as Equal-Weight by Stephens & Co. with a maintained price target of $350.
The reiteration of an Equal-Weight rating indicates that the analyst believes the stock is fairly valued at current levels. The maintained price target of $350 suggests that the analyst does not foresee significant upside or downside in the near term. This is likely to have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100